Luye Pharma Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:LUP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
08 Jun 26	Sell€22,691,133	UBS Asset Management AG	Company	106,797,500	€0.21
04 Jun 26	Buy€6,681,195	UBS Asset Management AG	Company	31,532,000	€0.21
02 Apr 26	Buy€4,402,988	UBS Asset Management AG	Company	13,954,500	€0.32
08 Sep 25	Sell€13,873,930	RRJ Capital	Company	33,000,000	€0.42
04 Sep 25	Sell€4,184,848	RRJ Capital	Company	10,000,000	€0.42
02 Sep 25	Buy€2,807,044	UBS Asset Management AG	Company	6,732,000	€0.42
22 Aug 25	Sell€2,712,257	RRJ Capital	Company	6,599,500	€0.41
13 Aug 25	Sell€4,601,705	RRJ Capital	Company	11,246,000	€0.41
30 Jul 25	Sell€3,172,064	UBS Asset Management AG	Company	6,959,500	€0.46

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LUP?
Owner Type	Number of Shares	Ownership Percentage
VC/PE Firms	552,324,108	13.8%
Institutions	626,686,937	15.7%
Private Companies	1,246,108,703	31.2%
General Public	1,569,396,205	39.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 60.27% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
31.2%	Luye Pharma Holdings Ltd.	1,246,108,703	€248.4m	0%	no data
13.8%	Hillhouse Investment Management, Ltd.	552,324,108	€110.1m	0%	no data
4.31%	UBS Asset Management AG	172,185,960	€34.3m	-32.2%	no data
1.67%	Vanguard Capital Management, LLC	66,801,456	€13.3m	1.75%	no data
1.33%	RRJ Capital	52,994,167	€10.6m	0%	no data
1.07%	Dimensional Fund Advisors LP	42,676,283	€8.5m	1.64%	no data
1.03%	China Universal Asset Management Company Ltd.	41,298,000	€8.2m	0%	no data
0.96%	BlackRock, Inc.	38,282,500	€7.6m	-1.01%	no data
0.74%	AEGON-Industrial Fund Management Co. Ltd.	29,639,500	€5.9m	0%	no data
0.65%	Bosera Asset Management Co., Ltd.	26,160,000	€5.2m	0%	no data
0.58%	Yinhua Fund Management Co., Ltd.	23,355,000	€4.7m	0%	no data
0.46%	Vanguard Fiduciary Trust Company	18,452,642	€3.7m	0%	no data
0.41%	American Century Investment Management Inc	16,498,000	€3.3m	7.59%	no data
0.32%	China Asset Management Co. Ltd.	12,805,000	€2.6m	0%	no data
0.31%	Bank of China Investment Management Co., Ltd.	12,327,500	€2.5m	0%	no data
0.27%	E Fund Management Co., Ltd.	10,679,424	€2.1m	0.68%	no data
0.22%	Fullgoal Fund Management Co. Ltd.	8,820,500	€1.8m	0%	no data
0.22%	HuaAn Fund Management Company Ltd.	8,788,500	€1.8m	0%	no data
0.22%	GF Fund Management Co., Ltd.	8,773,500	€1.7m	0%	no data
0.12%	State Street Global Advisors, Inc.	4,658,221	€928.5k	-2.42%	no data
0.089%	First State Cinda Fund Management Company Limited	3,549,000	€707.4k	0%	no data
0.073%	Minsheng Royal Fund Management Co., Ltd.	2,900,000	€578.0k	0%	no data
0.066%	Vanguard Asset Management, Limited	2,631,657	€524.5k	1.68%	no data
0.062%	Penghua Fund Management Co., Ltd.	2,465,500	€491.4k	0%	no data
0.058%	Charles Schwab Investment Management, Inc.	2,315,728	€461.5k	-0.34%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/26 00:46
End of Day Share Price	2026/06/26 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Luye Pharma Group Ltd. is covered by 16 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jessica Li	BofA Global Research
Lok Kwan Chiu	CCB International Securities Limited
Ling Zhang	China Merchants Securities (HK) Co., Ltd